Gyre Therapeutics Inc (NASDAQ: GYRE) closed the day trading at $17.48 down -0.29% from the previous closing price of $17.53. In other words, the price has decreased by -$0.05 from its previous closing price. On the day, 72408 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of GYRE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.88 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On February 10, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $15.
On May 21, 2020, Raymond James started tracking the stock assigning a Outperform rating and target price of $20.Raymond James initiated its Outperform rating on May 21, 2020, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 15 ’24 when USMAN NASSIM sold 20,000 shares for $17.26 per share. The transaction valued at 345,200 led to the insider holds 1,636 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GYRE now has a Market Capitalization of 1.50B and an Enterprise Value of 1.47B. Its current Enterprise Value per Revenue stands at 2.11 whereas that against EBITDA is 7.26.
Stock Price History:
Over the past 52 weeks, GYRE has reached a high of $30.40, while it has fallen to a 52-week low of $2.85. The 50-Day Moving Average of the stock is 16.88, while the 200-Day Moving Average is calculated to be 12.30.
Shares Statistics:
Over the past 3-months, GYRE traded about 84.28K shares per day on average, while over the past 10 days, GYRE traded about 52.86k shares per day. A total of 76.58M shares are outstanding, with a floating share count of 12.50M. Insiders hold about 83.68% of the company’s shares, while institutions hold 0.79% stake in the company.
Earnings Estimates
Current recommendations for the stock of the company come from 0 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$2.4. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
